-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Vistagen Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2010 to 2022.
- Vistagen Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $176K, a 351% increase year-over-year.
- Vistagen Therapeutics, Inc. Revenues for the twelve months ending March 31, 2023 was -$227K, a 120% decline year-over-year.
- Vistagen Therapeutics, Inc. annual Revenues for 2022 was -$227K, a 120% decline from 2021.
- Vistagen Therapeutics, Inc. annual Revenues for 2021 was $1.11M, a 1.79% increase from 2020.
- Vistagen Therapeutics, Inc. annual Revenues for 2020 was $1.09M.